• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC CARPENTIER-EDWARDS PERIMOUNT PLUS MITRAL PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC CARPENTIER-EDWARDS PERIMOUNT PLUS MITRAL PERICARDIAL BIOPROSTHESIS; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 6900PTFX
Medical Device Problem Codes Degraded (1153); Gradient Increase (1270)
Health Effect - Clinical Codes Stenosis (2263); Heart Failure/Congestive Heart Failure (4446)
Date of Event 11/18/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event or Problem Description
It was reported that a patient with a 33mm 6900ptfx mitral valve implanted for 5 years, 7 months, underwent a valve-in-valve procedure due to stenosis.The device was replaced with a 29mm 9600tfx transcatheter valve.
 
Event or Problem Description
It was reported that a patient with a 33mm 6900ptfx mitral valve implanted for 5 years, 7 months, underwent a valve-in-valve procedure due to degeneration of mitral valve bioprosthesis and severe ms.The patient presented with sob, chronic diastolic chf, nyha class iii.The tmvr was successfully performed with a 29mm 9600tfx transcatheter valve.The patient tolerated procedure well and was transferred to cardiac icu in stable condition for further management.
 
Additional Manufacturer Narrative
Updated sections b5, b7, d4 and h6 based on additional information received on 12/17/2021.
 
Additional Manufacturer Narrative
H10: additional manufacturer narrative: updated sections d4 (expiration date), h4 (manufactured date), h6 (type of investigation, investigation findings, investigation conclusions).Tissue degeneration-related structural deterioration, either calcific or non-calcific, are common chronic failure modes for this type of bioprosthetic heart valve.Operational mechanical stress and biological factors are generally believed to be the major contributors to the non-calcific bioprosthetic tissue degeneration.Structural valve deterioration (svd) can, and typically does, lead to chronic central leaks over a period of time.Svd is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly.Degeneration-related structural deterioration is most commonly related to patient factors and is not usually an indication of a device malfunction.The root cause of this was determined to be related to patient related factors.The stenosis and regurgitation in this case were impacted by the progression of the patient's underlying valvular disease pathology with structural valve deterioration.The subject device is not available for evaluation, as it remains implanted in the patient.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PERIMOUNT PLUS MITRAL PERICARDIAL BIOPROSTHESIS
Common Device Name
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
1 edwards way
mailstop ant 6.1
irvine, CA 92614
9492502731
MDR Report Key12992261
Report Number2015691-2021-06810
Device Sequence Number5301950
Product Code DYE
UDI-Device Identifier00690103163629
UDI-Public(01)00690103163629(17)190126
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P860057
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/26/2019
Device Model Number6900PTFX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/18/2021
Supplement Date Received by Manufacturer12/17/2021
01/19/2022
Initial Report FDA Received Date12/14/2021
Supplement Report FDA Received Date01/06/2022
01/24/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/27/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Life Threatening; Required Intervention;
Patient Age84 YR
Patient SexFemale
-
-